DAN, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 1.593
AS - Asia 1.544
EU - Europa 1.361
AF - Africa 127
SA - Sud America 65
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 6
Totale 4.712
Nazione #
US - Stati Uniti d'America 1.572
VN - Vietnam 455
IT - Italia 452
SG - Singapore 405
CN - Cina 354
GB - Regno Unito 191
SE - Svezia 148
DE - Germania 127
NL - Olanda 91
HK - Hong Kong 82
IE - Irlanda 65
IN - India 63
FR - Francia 60
RU - Federazione Russa 47
FI - Finlandia 45
KR - Corea 45
BR - Brasile 40
CI - Costa d'Avorio 32
TG - Togo 31
ZA - Sudafrica 28
JP - Giappone 22
AT - Austria 19
BG - Bulgaria 18
SC - Seychelles 18
ES - Italia 17
JO - Giordania 17
CH - Svizzera 15
EU - Europa 15
UA - Ucraina 15
CA - Canada 13
EE - Estonia 13
AR - Argentina 12
PK - Pakistan 12
PL - Polonia 12
TH - Thailandia 11
ID - Indonesia 9
NG - Nigeria 9
BD - Bangladesh 8
PH - Filippine 8
TR - Turchia 7
BE - Belgio 6
IQ - Iraq 6
TW - Taiwan 6
AU - Australia 5
MX - Messico 5
MY - Malesia 5
SA - Arabia Saudita 5
CL - Cile 4
IR - Iran 4
LT - Lituania 4
UZ - Uzbekistan 4
CO - Colombia 3
CZ - Repubblica Ceca 3
MA - Marocco 3
PT - Portogallo 3
BW - Botswana 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NO - Norvegia 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BH - Bahrain 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 4.712
Città #
Singapore 284
Ashburn 208
Bologna 156
Southend 156
Chandler 153
Fairfield 145
Ho Chi Minh City 127
Hanoi 120
San Jose 85
Hong Kong 73
Hefei 70
Dublin 63
Seattle 61
Houston 57
New York 55
Woodbridge 50
Beijing 49
Wilmington 43
Cambridge 39
Seoul 37
Princeton 36
Abidjan 32
Helsinki 32
Santa Clara 32
Lomé 31
Ann Arbor 28
Los Angeles 28
Boardman 27
Lauterbourg 23
Dallas 22
Munich 22
Haiphong 21
Da Nang 18
Sofia 17
Tokyo 17
Nanjing 16
Turin 16
Amman 15
Buffalo 15
Florence 15
Frankfurt am Main 15
Guangzhou 15
Westminster 14
Bern 13
Bremen 13
Castel Maggiore 12
Milan 12
Padova 12
Vienna 12
Redmond 11
Rome 11
Amsterdam 10
London 10
Nuremberg 10
Johannesburg 9
Redondo Beach 9
Abeokuta 8
Brooklyn 8
Council Bluffs 8
San Francisco 8
Toronto 8
Bengaluru 7
Berlin 7
Bexley 7
Biên Hòa 7
Bến Tre 7
Changsha 7
Jakarta 7
Jinan 7
Lecce 7
Phoenix 7
Pisa 7
San Diego 7
Tianjin 7
Turku 7
Warsaw 7
Zhengzhou 7
Bangkok 6
Lappeenranta 6
Quận Ba 6
Redwood City 6
Saint Petersburg 6
São Paulo 6
The Dalles 6
Vicenza 6
Boston 5
Boydton 5
Brussels 5
Can Tho 5
Hyderabad 5
Hải Dương 5
Istanbul 5
Medford 5
Paris 5
Stockholm 5
Tân Tiến 5
Washington 5
York 5
Hangzhou 4
Jeddah 4
Totale 2.955
Nome #
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 295
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 222
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation 218
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 215
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy 208
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 208
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome 199
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells 198
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 197
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 196
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 195
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice 187
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 184
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 183
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 182
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 175
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. 168
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 159
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors 153
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 149
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 146
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 143
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 141
Epigenetic age acceleration in hematopoietic stem cell transplantation 132
CD133+ stem cells for the treatment of end-stage liver disease 104
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 90
null 86
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients 59
Totale 4.792
Categoria #
all - tutte 12.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 16 5 17
2021/2022381 13 30 8 30 35 14 9 26 18 50 85 63
2022/2023642 66 96 34 74 44 49 25 39 98 9 64 44
2023/2024258 23 34 16 33 18 80 5 9 3 18 13 6
2024/2025882 44 92 71 61 70 49 64 54 27 119 97 134
2025/20261.859 169 169 136 182 186 84 245 85 454 149 0 0
Totale 4.792